Nevro Corp (NVRO) - Financial and Strategic SWOT Analysis Review
![](/report_cover/1896/nevro-corp-nvro-financial-n-strategic-swot-analysis-review_en.gif)
Nevro Corp (NVRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Nevro Corp (Nevro) is a medical device company which focuses on providing novel products that advance the quality of life of people suffering from chronic pain in trunks and limbs. The company has developed Nevro Senza spinal cord stimulation (SCS) system, a non-pharmacologic neuromodulation platform for the treatment of chronic pain. The Nevro Senza SCS system is commercially available in the US, Europe and Australia. The company offers products under Senza, Senza II, Senza Omnia and the Nevro logo brands. Nevro is developing HF10 therapy for treating painful diabetic neuropathy and non-surgical refractory back pain. Nevro is headquartered in Redwood City, California, the US.
Nevro Corp Key Recent Developments
Apr 13,2021: Nevro to Present at BofA Securities 2021 Virtual Health Care Conference
Feb 24,2021: Nevro reports fourth quarter and full year 2020 financial results
Jan 11,2021: Nevro announces preliminary, unaudited fourth quarter and full-year 2020 revenue
Dec 14,2020: Boston Scientific announces stipulation of dismissal of Nevro Corporation's patent infringement case in California
Dec 03,2020: Nevro announces director appointment
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Nevro Corp (Nevro) is a medical device company which focuses on providing novel products that advance the quality of life of people suffering from chronic pain in trunks and limbs. The company has developed Nevro Senza spinal cord stimulation (SCS) system, a non-pharmacologic neuromodulation platform for the treatment of chronic pain. The Nevro Senza SCS system is commercially available in the US, Europe and Australia. The company offers products under Senza, Senza II, Senza Omnia and the Nevro logo brands. Nevro is developing HF10 therapy for treating painful diabetic neuropathy and non-surgical refractory back pain. Nevro is headquartered in Redwood City, California, the US.
Nevro Corp Key Recent Developments
Apr 13,2021: Nevro to Present at BofA Securities 2021 Virtual Health Care Conference
Feb 24,2021: Nevro reports fourth quarter and full year 2020 financial results
Jan 11,2021: Nevro announces preliminary, unaudited fourth quarter and full-year 2020 revenue
Dec 14,2020: Boston Scientific announces stipulation of dismissal of Nevro Corporation's patent infringement case in California
Dec 03,2020: Nevro announces director appointment
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Nevro Corp - Key Facts
Nevro Corp - Key Employees
Nevro Corp - Key Employee Biographies
Nevro Corp - Major Products and Services
Nevro Corp - History
Nevro Corp - Company Statement
Nevro Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Nevro Corp - Business Description
Geographical Segment: International
Target Markets
Performance
Geographical Segment: The US
Performance
R&D Overview
Nevro Corp - Corporate Strategy
Nevro Corp - SWOT Analysis
SWOT Analysis - Overview
Nevro Corp - Strengths
Nevro Corp - Weaknesses
Nevro Corp - Opportunities
Nevro Corp - Threats
Nevro Corp - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Nevro Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Nevro Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Nevro Corp, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Apr 13, 2021: Nevro to Present at BofA Securities 2021 Virtual Health Care Conference
Feb 24, 2021: Nevro reports fourth quarter and full year 2020 financial results
Jan 11, 2021: Nevro announces preliminary, unaudited fourth quarter and full-year 2020 revenue
Dec 14, 2020: Boston Scientific announces stipulation of dismissal of Nevro Corporation's patent infringement case in California
Dec 03, 2020: Nevro announces director appointment
Nov 30, 2020: Nevro appoints Julie D. Dewey as vice president, investor relations and corporate communications
Nov 05, 2020: Nevro announces third quarter 2020 financial results
Sep 14, 2020: Nevro initiates plan for manufacturing operations in Costa Rica to support future growth
Aug 05, 2020: Nevro announces second quarter 2020 financial results
Jun 04, 2020: Nevro appoints finance executive Roderick MacLeod as Chief Financial Officer
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Nevro Corp - Key Facts
Nevro Corp - Key Employees
Nevro Corp - Key Employee Biographies
Nevro Corp - Major Products and Services
Nevro Corp - History
Nevro Corp - Company Statement
Nevro Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Nevro Corp - Business Description
Geographical Segment: International
Target Markets
Performance
Geographical Segment: The US
Performance
R&D Overview
Nevro Corp - Corporate Strategy
Nevro Corp - SWOT Analysis
SWOT Analysis - Overview
Nevro Corp - Strengths
Nevro Corp - Weaknesses
Nevro Corp - Opportunities
Nevro Corp - Threats
Nevro Corp - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Nevro Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Nevro Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Nevro Corp, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Apr 13, 2021: Nevro to Present at BofA Securities 2021 Virtual Health Care Conference
Feb 24, 2021: Nevro reports fourth quarter and full year 2020 financial results
Jan 11, 2021: Nevro announces preliminary, unaudited fourth quarter and full-year 2020 revenue
Dec 14, 2020: Boston Scientific announces stipulation of dismissal of Nevro Corporation's patent infringement case in California
Dec 03, 2020: Nevro announces director appointment
Nov 30, 2020: Nevro appoints Julie D. Dewey as vice president, investor relations and corporate communications
Nov 05, 2020: Nevro announces third quarter 2020 financial results
Sep 14, 2020: Nevro initiates plan for manufacturing operations in Costa Rica to support future growth
Aug 05, 2020: Nevro announces second quarter 2020 financial results
Jun 04, 2020: Nevro appoints finance executive Roderick MacLeod as Chief Financial Officer
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Nevro Corp, Key Facts
Nevro Corp, Key Employees
Nevro Corp, Key Employee Biographies
Nevro Corp, Major Products and Services
Nevro Corp, History
Nevro Corp, Subsidiaries
Nevro Corp, Key Competitors
Nevro Corp, Ratios based on current share price
Nevro Corp, Annual Ratios
Nevro Corp, Annual Ratios (Cont...1)
Nevro Corp, Interim Ratios
Nevro Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Nevro Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Nevro Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Nevro Corp, Key Facts
Nevro Corp, Key Employees
Nevro Corp, Key Employee Biographies
Nevro Corp, Major Products and Services
Nevro Corp, History
Nevro Corp, Subsidiaries
Nevro Corp, Key Competitors
Nevro Corp, Ratios based on current share price
Nevro Corp, Annual Ratios
Nevro Corp, Annual Ratios (Cont...1)
Nevro Corp, Interim Ratios
Nevro Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Nevro Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Nevro Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Nevro Corp, Performance Chart (2016 - 2020)
Nevro Corp, Ratio Charts
Nevro Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Nevro Corp, Medical Equipment, Deals by Type, 2015 to YTD 2021
Nevro Corp, Performance Chart (2016 - 2020)
Nevro Corp, Ratio Charts
Nevro Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Nevro Corp, Medical Equipment, Deals by Type, 2015 to YTD 2021